BP1, a potential biomarker for breast cancer prognosis

被引:13
作者
Lou, Yaoxian [1 ]
Fallah, Yassi [2 ]
Yamane, Kellie [3 ]
Berg, Patricia E. [1 ]
机构
[1] George Washington Univ, Dept Biochem & Mol Med, Washington, DC 20037 USA
[2] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA
[3] NantOmics, Diagnost Ctr Montgomery Cty, Rockville, MD 20850 USA
关键词
biomarker; BP1; target; breast cancer; distal; less family; DLX4; estrogen receptor; homeobox genes; isoform; oncogene; HOMEOBOX GENE; MESSENGER-RNA; ANTENNAPEDIA HOMEODOMAIN; TAMOXIFEN RESISTANCE; EXPRESSION LEVEL; PROTEIN; DLX4; HOMEOPROTEIN; HOXB7; BETA;
D O I
10.2217/bmm-2017-0212
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Homeobox genes are critical in tumor development. An isoform protein of DLX4 called BP1 is expressed in 80% of invasive ductal breast carcinomas. BP1 overexpression is implicated in an aggressive phenotype and poor prognosis. BP1 upregulation is associated with estrogen receptor negativity so those tumors do not respond to antiestrogens. Breast cancer is the second leading cause of death in women. BP1 could serve as both a novel prognostic biomarker for breast cancer and a therapeutic target. In this review, we address the role of BP1 protein in tumorigenesis of breast cancer and four other malignancies. A number of functions of BP1 in cancer are also discussed.
引用
收藏
页码:535 / 545
页数:11
相关论文
共 51 条
[1]   Deregulated homeobox gene expression in cancer: Cause or consequence? [J].
Abate-Shen, C .
NATURE REVIEWS CANCER, 2002, 2 (10) :777-785
[2]   Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells [J].
Awwad, Rania T. ;
Do, Khanh ;
Stevenson, Holly ;
Fu, Sidney W. ;
Lo-Coco, Francesco ;
Costello, Maura ;
Campbell, Cassandra L. ;
Berg, Patricia E. .
ANNALS OF HEMATOLOGY, 2008, 87 (03) :195-203
[3]  
Berg PE, 2011, ATLAS GENET CYTOGENE, V15, P658
[4]   DETERMINATION OF THE 3-DIMENSIONAL STRUCTURE OF THE ANTENNAPEDIA HOMEODOMAIN FROM DROSOPHILA IN SOLUTION BY H-1 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
BILLETER, M ;
QIAN, Y ;
OTTING, G ;
MULLER, M ;
GEHRING, WJ ;
WUTHRICH, K .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 214 (01) :183-197
[5]   In vivo expression of the whole HOX gene network in human breast cancer [J].
Cantile, M ;
Pettinato, G ;
Procino, A ;
Feliciello, I ;
Cindolo, L ;
Cillo, C .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (02) :257-264
[6]  
Carè A, 2001, CANCER RES, V61, P6532
[7]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[8]   Amplification of the BP1 homeobox gene in breast cancer [J].
Cavalli, Luciane R. ;
Man, Yan-Gao ;
Schwartz, Arnold M. ;
Rone, Janice D. ;
Zhang, Ying ;
Urban, Cicero A. ;
Lima, Rubens S. ;
Haddad, Bassem R. ;
Berg, Patricia E. .
CANCER GENETICS AND CYTOGENETICS, 2008, 187 (01) :19-24
[9]   Tamoxifen Resistance in Breast Cancer [J].
Chang, Minsun .
BIOMOLECULES & THERAPEUTICS, 2012, 20 (03) :256-267
[10]   BP1, a homeodomain-containing isoform of DLX4, represses the β-globin gene [J].
Chase, MB ;
Fu, SD ;
Haga, SB ;
Davenport, G ;
Stevenson, H ;
Do, K ;
Morgan, D ;
Mah, AL ;
Berg, PE .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2505-2514